Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-06-13 Purchase | 2024-06-14 4:05 pm | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner | 22,617,909 | $2.42 | $54,735,340 | 22,617,909 (Indirect) | View |
| 2023-06-28 Purchase | 2023-06-28 4:01 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 130,000 | $29.51 | $3,836,768 | 3,758,980 (Indirect Direct) | View |
| 2023-06-12 Purchase | 2023-06-13 4:01 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 90,000 | $32.89 | $2,959,848 | 3,628,980 (Indirect Direct) | View |
| 2023-05-24 Purchase | 2023-05-24 6:45 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 150,000 | $32.25 | $4,837,440 | 3,538,980 (Indirect Direct) | View |
| 2023-05-16 Purchase | 2023-05-17 6:41 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 230,000 | $33.38 | $7,676,824 | 3,388,980 (Indirect Direct) | View |
| 2022-01-31 Purchase | 2022-02-01 4:17 pm | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner | 22,666,667 | $1.5 | $34,000,001 | 31,930,464 (Indirect Direct) | View |
| 2020-06-18 Purchase | 2020-06-22 9:55 pm | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 20,000 | $28 | $560,000 | 7,885,433 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-30 Option Award | 2024-06-03 4:33 pm | N/A 2034-05-30 | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Director | 62,558 | $0 | 62,558 (Direct) | View |
| 2024-02-05 Conversion | 2024-02-06 4:05 pm | N/A N/A | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner | 1,497,904 | $0 | 178,028,874 (Indirect) | View |
| 2024-02-05 Other | 2024-02-06 4:05 pm | N/A N/A | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner | 748,952 | $0 | 178,028,874 (Indirect) | View |
| 2022-12-30 Gift | 2023-11-16 5:50 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 292,190 | $0 | 4,051,170 (Indirect) | View |
| 2023-11-16 Other | 2023-11-16 5:50 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 383,000 | $0 | 4,051,170 (Direct) | View |
| 2023-10-30 Conversion | 2023-11-01 5:27 pm | N/A N/A | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner | 10,578,110 | $0 | 184,066,881 (Indirect) | View |
| 2023-10-30 Other | 2023-11-01 5:27 pm | N/A N/A | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner | 5,289,055 | $0 | 184,066,881 (Indirect) | View |
| 2023-06-29 Option Award | 2023-07-03 09:16 am | N/A 2033-06-29 | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Director 10% Owner | 48,128 | $0 | 48,128 (Direct) | View |
| 2023-05-12 Gift | 2023-05-15 9:34 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 20,538 | $0 | 1,700,189 (Indirect) | View |
| 2022-08-12 Ownership | 2023-02-10 7:48 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 150,640 | $0 | 5,709,377 (Indirect) | View |
Ownership | 2023-02-10 7:48 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 0 | $0 | 5,709,377 (Indirect) | View |
| 2022-08-12 Equity Swap | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 31,933,334 | $0 | 0 (Indirect) | View |
| 2022-08-12 Disposition | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 17,054 | $0 | 0 (Direct) | View |
| 2022-07-11 Option Award | 2022-07-13 9:30 pm | N/A N/A | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner | 199,855,936 | $0 | 199,855,936 (Indirect) | View |
Ownership | 2022-07-13 9:06 pm | N/A N/A | PROKIDNEY CORP. | PROK | Legorreta Pablo G. Tolerantia LLC Director 10% Owner | 0 | $0 | 0 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 6:01 pm | 2023-05-17 2032-05-16 | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 41,006 | $0.56 | 31,980,464 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 6:01 pm | 2023-05-17 N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 8,994 | $0 | 31,980,464 (Direct) | View |
| 2020-06-16 Conversion | 2022-04-15 6:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 1,198,821 | $0 | 36,641,176 (Indirect) | View |
| 2021-03-23 Other | 2022-04-15 6:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 917,322 | $0 | 36,641,176 (Indirect) | View |
| 2020-06-15 Option Award(A) | 2022-04-15 6:49 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 1,719,074 | $0 | 1,719,074 (Indirect) | View |
Ownership(A) | 2022-04-15 6:45 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 0 | $0 | 12,106,264 (Indirect) | View |
| 2021-06-11 Option Award | 2021-06-15 5:14 pm | 2022-06-11 2031-06-11 | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner | 40,559 | $8.53 | 9,263,797 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 5:14 pm | 2022-06-11 N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner | 8,060 | $0 | 9,263,797 (Direct) | View |
| 2021-05-07 Conversion | 2021-05-11 9:03 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 2,557,500 | $0 | 7,406,417 (Indirect) | View |
| 2020-06-15 Option Award | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 7,765,047 | $0 | 7,885,433 (Indirect) | View |
| 2020-06-18 Conversion | 2020-06-22 9:55 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board 10% Owner | 265,991 | $0 | 7,885,433 (Indirect) | View |
Ownership | 2020-06-15 9:56 pm | N/A N/A | Royalty Pharma plc | RPRX | Legorreta Pablo G. CEO, Chairman of the Board | 0 | $0 | 62,552,304 (Indirect) | View |
| 2020-05-29 Option Award | 2020-06-02 4:23 pm | 2021-05-29 2029-05-29 | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner | 14,103 | $0 | 9,215,178 (Direct) | View |
| 2020-02-11 Option Award | 2020-02-13 6:47 pm | N/A N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director 10% Owner | 2,500,000 | $20 | 11,701,075 (Indirect) | View |
| 2019-11-06 Option Award | 2019-11-08 7:10 pm | N/A 2029-11-05 | Epizyme Inc. | EPZM | Legorreta Pablo G. Director | 34,408 | $0 | 34,408 (Direct) | View |
Ownership | 2019-11-08 7:07 pm | N/A N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Director | 0 | $0 | 9,166,667 (Indirect) | View |